A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

Clinical trial NCT07498465 · WITHDRAWN

Trial details

NCT number: NCT07498465
Sponsor: Children's Oncology Group
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Childhood Acute Lymphoblastic Leukemia Childhood Acute Myeloid Leukemia Childhood Mixed Phenotype Acute Leukemia Mixed Phenotype Acute Leukemia

Start date: 2026-09-10
Primary completion: 2028-11-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.